Responses
Oncology
Protocol
Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.